Design Optimization in Nonlinear Mixed Effects Models Using Cost Functions: Application to a Joint Model of Infliximab and Methotrexate Pharmacokinetics
DOI10.1080/03610920902833511zbMath1177.62094OpenAlexW2005899787MaRDI QIDQ3652668
Emmanuelle Comets, France Mentré, Caroline Bazzoli, Sylvie Retout
Publication date: 16 December 2009
Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://www.hal.inserm.fr/inserm-00424247/file/Retout_Comm_in_stat_2009.pdf
PFIMcost functiondesign optimizationFisher information matrixnonlinear mixed effects modelFedorov-Wynn algorithm
Optimal statistical designs (62K05) Computer science aspects of computer-aided design (68U07) Medical applications (general) (92C50)
Uses Software
Cites Work
- Maximum likelihood estimation in nonlinear mixed effects models
- Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model
- Relative efficiency of unequal cluster sizes for variance component estimation in cluster randomized and multicentre trials
- Optimal design in random-effects regression models
- A maximum likelihood estimation method for random coefficient regression models
- Design of experiments with unknown parameters in variance
- Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics
This page was built for publication: Design Optimization in Nonlinear Mixed Effects Models Using Cost Functions: Application to a Joint Model of Infliximab and Methotrexate Pharmacokinetics